Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
PaperCitations, authors & open-access status
Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 433 citations, 2014 year and bronze oa status.
433
Citations
2014
Year
bronze
OA Status